Nir Nimrodi

Nir Nimrodi is an accomplished executive with extensive experience in the life sciences and biotechnology sectors. Currently serving as a Board Member for Scopio Labs, OdysightAI, Genesee Scientific, and Evogene, Nir demonstrates expertise in digital imaging, predictive maintenance, and life science product development. As Chairman of the Board and CEO at Accellix, Nir has advanced automated cell analysis technology, while previous roles at Intrexon Corporation and Life Technologies involved significant commercial transformation and revenue growth. With leadership experience as CEO at Proneuron Biotechnologies, Nir led pioneering advancements in spinal cord injury treatments and has a strong foundation in finance from Teva Pharmaceuticals. Nir holds an MBA and a Bachelor's degree in Economics from Tel Aviv University.